Connect your AI

Kura Oncology KURA Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Syndax PharmaceuticalsSNDX

$1.21M-32.7%

Corvus PharmaceuticalsCRVS

$751K-31.4%

Nuvation BioNUVB

$3.6M-32.5%

Cullinan Therapeutics, Inc.CGEM

$2.44M+57.2%

IncyteINCY

$26.67M-10.8%

SELLAS Life Sciences Group, Inc.SLS

$839K+4.1%

Other financials

Income statement

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Kura Oncology's operating lease ROU assets?: Kura Oncology (KURA) reported operating lease ROU assets of $7.17M in Q1 2026.
How has Kura Oncology's operating lease ROU assets changed year-over-year?: Kura Oncology's operating lease ROU assets decreased by 12.0% year-over-year, from $8.14M to $7.17M.
What is the long-term trend for Kura Oncology's operating lease ROU assets?: Over 5 years (2020 to 2025), Kura Oncology's operating lease ROU assets has grown at a 2.9% compound annual growth rate (CAGR), from $6.33M to $7.3M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.